Yeliz Yalçın
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yeliz Yalçın has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Ishak Ozel Tekin
Department of Immunology
2 shared publications - Rahime Seda Tığlı Aydın
Department of Biomedical Engineering, Zonguldak Bulent Ecevit University, Zonguldak, Turkey
2 shared publications
Latest Publications
- 1 June 2022
- Published by Bulent Evcevit University in Karaelmas Science and Engineering Journal
- Vol. 12 (1) , 38-46
Nano Ozonized Oil Trigger ROS Production and ɣH2AX Cell Positivity of B-16 Melanoma and OV-90 Ovarian Cells
Tumor hypoxia is a restrictive factor for cancer treatment. Ozone therapy, used to decrease or prevent the hypoxia in tumor. In this study, it is aimed to use ozonized oil nanoemulsions (OZNEs) to overcome the limitations of ozone therapy in cancer research. The influence of OZNE against cancer cell lines is evaluated by Reactive Oxygen Species (ROS) and ɣH2AX assays. For both B-16 melanoma and OV-90 cell lines, ROS production levels increased due to the increase in OZNE doses (0.85% to 14.88% and 1.94% to 58.58% for B-16 and OV-90 cell lines, respectively). 5-fold higher ɣH2AX cell positivity’s determined in OV-90 cells compared to B-16 melanoma cells. OZNE treatment could provide a new effective method to damage cancer cells in the future.
- 1 June 2022
- Published by Bulent Evcevit University in Karaelmas Science and Engineering Journal
- Vol. 12 (1) , 38-46
Nano Ozonized Oil Trigger ROS Production and ɣH2AX Cell Positivity of B-16 Melanoma and OV-90 Ovarian Cells
Tumor hypoxia is a restrictive factor for cancer treatment. Ozone therapy, used to decrease or prevent the hypoxia in tumor. In this study, it is aimed to use ozonized oil nanoemulsions (OZNEs) to overcome the limitations of ozone therapy in cancer research. The influence of OZNE against cancer cell lines is evaluated by Reactive Oxygen Species (ROS) and ɣH2AX assays. For both B-16 melanoma and OV-90 cell lines, ROS production levels increased due to the increase in OZNE doses (0.85% to 14.88% and 1.94% to 58.58% for B-16 and OV-90 cell lines, respectively). 5-fold higher ɣH2AX cell positivity’s determined in OV-90 cells compared to B-16 melanoma cells. OZNE treatment could provide a new effective method to damage cancer cells in the future.
- 13 May 2022
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 615, 143-149
Ionizing radiation induced DNA damage via ROS production in nano ozonized oil treated B-16 melanoma and OV-90 ovarian cells
- 13 May 2022
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 615, 143-149
Ionizing radiation induced DNA damage via ROS production in nano ozonized oil treated B-16 melanoma and OV-90 ovarian cells